Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase peripheral stalk subunit F6 is a nuclear-encoded protein component of the mammalian mitochondrial ATP synthase complex (complex V). It forms a critical part of the peripheral stalk (stator), which anchors the enzyme’s catalytic head (F1 sector) to the membrane sector (FO) and prevents its rotation as protons drive rotary catalysis for synthesis of ATP from ADP and inorganic phosphate[1][2]. F6 interacts with other stator proteins such as subunit b, OSCP, and subunit d. Mutation or loss of F6 disrupts complex assembly and coupling between proton movement and ATP production, severely impairing mitochondrial function[2]. Although ATP synthase is a validated therapeutic target in some contexts (especially in infectious disease and cancer research), direct small-molecule targeting of the F6 subunit has not been reported, and inhibitors act broader on the complex. F6 is encoded in humans by the ATP5J gene and is analogous to subunit h in yeast[2].
Inhibition of ATP synthase (prevents ATP production by disrupting proton channel or complex stability)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase peripheral stalk subunit F6 (F6).